Thread
:
Genentech receives FDA approval for Kadcyla to treat HER2-positive metastatic breast
View Single Post
02-22-2013, 11:10 PM
#
1
News
Senior Member
Join Date: Oct 2007
Posts: 18,987
Genentech receives FDA approval for Kadcyla to treat HER2-positive metastatic breast
The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer.
More...
News
View Public Profile
Send a private message to News
Find More Posts by News